Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. The suitability of RWD, the FDA said in a 2017 guidance report , depends on its relevance (whether data directly addresses intended use) and reliability (completeness, accuracy and timeliness) [2].

Patients 59

Patients Biopharma Medical science Electronics 59

PM360

DECEMBER 20, 2024

When the first biosimilars were approved by the FDA almost a decade ago, they were expected to provide a cost-effective alternative to expensive biologics, improve accessibility for patients and reduce healthcare spending by creating competition in the biologic market. Regional Account Manager, and Shaun Terry, Sr.

Physicians 52

Physicians Marketing Competition Management 52

Medgadget

MARCH 2, 2023

The first human trial done in Israel proved very successful (2017-2018, finalized during COVID), and published in the Red Journal , the official journal of the American Society for Radiation Oncology), involving many patients whose cancer recurred after treatment or whose options were exhausted. which are currently recruiting patients.

Manufacturing 82

Manufacturing Leads Patients Medicine 82

European Pharmaceutical Review

MAY 23, 2024

Last month, CARVYKTI ® (ciltacabtagene autoleucel; cilta-cel) was the first BCMA-targeted CAR-T cell therapy to be approved for second-line treatment of multiple myeloma by the US Food and Drug Administration (FDA). Most recently, Imran has served as Medical Science Liaison (MSL) Head, Oncology U.S. Medical Affairs.

Food and Drug Administration 110

Food and Drug Administration Food Medical Medicine 110